Heteroaryl substituted pyrazinylpiperazine-piperidines with CXCR3 antagonist activity
Details for Australian Patent Application No. 2006216941 (hide)
International Classifications
Event Publications
23 August 2007 PCT application entered the National Phase
PCT publication WO2006/091428 Priority application(s): WO2006/091428
19 November 2009 Alteration of Name
The name of the applicant has been altered to Schering Corporation; Pharmacopeia, LLC
3 December 2009 Application Accepted
Published as AU-B-2006216941
1 April 2010 Standard Patent Sealed
8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006216946-Nail advancement systems for nail arrays disposed within nailing tool magazines
2006216939-Methods and apparatus for extracting and analyzing a bodily fluid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser